Zobrazeno 1 - 10
of 202
pro vyhledávání: '"Ovarian epithelial carcinoma"'
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 63, Iss 5, Pp 601-609 (2024)
Ovarian cancer stands as the third most prevalent gynecological malignancy. The advent of PARP inhibitors, particularly rucaparib, has revolutionized the landscape of advanced ovarian cancer treatment, demonstrating notable efficacy with minimal toxi
Externí odkaz:
https://doaj.org/article/a1cf2c54a9ac4fc898e1bff0fe8f2999
Autor:
Hua Yang, Xiangyu Gu, Rong Fan, Qun Zhu, Sen Zhong, Xirun Wan, Qian Chen, Lan Zhu, Fengzhi Feng
Publikováno v:
Journal of Ovarian Research, Vol 16, Iss 1, Pp 1-11 (2023)
Abstract Background Ovarian cancer is a significant public health concern with a poor prognosis for epithelial ovarian cancer. To explore the potential of immunotherapy in treating epithelial ovarian cancer, we investigated the immune microenvironmen
Externí odkaz:
https://doaj.org/article/142be1aaedb84faeaa6b80daf55f0169
Autor:
Menon Usha, Gentry-Maharaj Aleksandra, Burnell Matthew, Ryan Andy, Kalsi Jatinderpal K, Singh Naveena, Dawnay Anne, Fallowfield Lesley, McGuire Alistair J, Campbell Stuart, Skates Steven J, Parmar Mahesh, Jacobs Ian J
Publikováno v:
Health Technology Assessment (2023)
Background Ovarian and tubal cancers are lethal gynaecological cancers, with over 50% of the patients diagnosed at advanced stage. Trial design Randomised controlled trial involving 27 primary care trusts adjacent to 13 trial centres based at NHS Tru
Externí odkaz:
https://doaj.org/article/b38b3c1cc47244c5afd068e650ac4ac7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Li Pang, Shizhuo Wang
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Small-cell carcinomas are highly malignant tumors with neuroendocrine function and which often occur in the lungs. Primary small-cell neuroendocrine carcinomas of the gynecologic tract are extremely rare. This study aimed to evaluate the prevalence o
Externí odkaz:
https://doaj.org/article/482e739938954cf2a499502025625a7a
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background As we all know, patients with epithelial ovarian carcinoma have poor prognosis and high recurrence rate. It is critical and challenging to screen out the patients with high risk of recurrence. At present, there are some models pre
Externí odkaz:
https://doaj.org/article/e4f5543ba94e4aa28456b0c34cc2f533
LncRNA TONSL-AS1 regulates miR-490-3p/CDK1 to affect ovarian epithelial carcinoma cell proliferation
Publikováno v:
Journal of Ovarian Research, Vol 13, Iss 1, Pp 1-6 (2020)
Abstract Background LncRNA TONSL-AS1 has been characterized as a critical player in gastric cancer. By analyze the TCGA dataset, we observed the upregulation of TONSL-AS1 in ovarian epithelial carcinoma (EOC). We therefore investigated the involvemen
Externí odkaz:
https://doaj.org/article/724f707fb43040e0921fd9d6eacc50f7
Autor:
Hyun Park, Sohyun Hwang, Ju-Yeon Jeong, Sang Geun Jung, Min Chul Choi, Won Duk Joo, Seung Hun Song, Chan Lee, Hee Jung An
Publikováno v:
Journal of Ovarian Research, Vol 13, Iss 1, Pp 1-10 (2020)
Abstract Background Cancer stem cells (CSCs) can self-renew, proliferate into differentiated cells, or enter a quiescent state and are regarded to cause chemoresistance and recurrence. An integrative analysis of transcription factors (TF) and miRNAs
Externí odkaz:
https://doaj.org/article/c4ed98091bd9460fa0cd55185302d6bd
Autor:
So Young Kim, Kyung Un Choi, Chungsu Hwang, Hyung Jung Lee, Jung Hee Lee, Dong Hoon Shin, Jee Yeon Kim, Mee Young Sol, Jae Ho Kim, Ki Hyung Kim, Dong Soo Suh, Byung Su Kwon
Publikováno v:
Journal of Pathology and Translational Medicine, Vol 53, Iss 4, Pp 244-252 (2019)
Background Ovarian epithelial cancer (OEC) is the second-most common gynecologic malignancy. CD109 expression is elevated in human tumor cell lines and carcinomas. A previous study showed that CD109 expression is elevated in human tumor cell lines an
Externí odkaz:
https://doaj.org/article/e0a999c379d94c82afc2b63092654025